Neuros Medical, a US-based provider of implantable neurostimulation devices, has raised $3.5m in its extended series A round from a consortium co-led by peer Boston Scientific.
Alongside Boston Scientific in the A-1 round are venture capital firms Glengary Ventures, RiverWest Venture Partners, ModelVest, Blue Tree Allied Angels, Case Tech Ventures, JumpStart Ventures, NorthCoast Angel Fund, Ohio Tech Angel Fund, Queen City Angel Fund III and Physician Investment Group.
Neuros raised $1.9m in it’s A round in October 2009.
Jon Snyder, executive president of Neuros Medical, said: “Having the strong support of our current investors, as well as from a well-respected industry leader in Boston Scientific, sends a strong signal that our execution to date and efforts going forward are well received.”